Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies
The American Journal of Pathology, ISSN: 0002-9440, Vol: 193, Issue: 10, Page: 1485-1500
2023
- 11Citations
- 15Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes11
- 11
- CrossRef6
- Captures15
- Readers15
- 15
Review Description
Mitochondria are cellular power stations and essential organelles for maintaining cellular homeostasis. Dysfunctional mitochondria have emerged as a key factor in the occurrence and development of cardiovascular disease. This review focuses on advances in the relationship between mitochondrial dysfunction and cardiovascular diseases such as atherosclerosis, heart failure, myocardial ischemia reperfusion injury, and pulmonary arterial hypertension. The clinical value and challenges of mitochondria-targeted strategies, including mitochondria-targeted antioxidants, mitochondrial quality control modulators, mitochondrial function protectors, mitochondrial biogenesis promoters, and recently developed mitochondrial transplants, are also discussed.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0002944023002456; http://dx.doi.org/10.1016/j.ajpath.2023.06.013; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85171345767&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37481069; https://linkinghub.elsevier.com/retrieve/pii/S0002944023002456; https://dx.doi.org/10.1016/j.ajpath.2023.06.013
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know